Fed. Circ. Says PTAB Violated Process In NuVasive Review
The Federal Circuit ruled Wednesday that the Patent Trial and Appeal Board violated the Administrative Procedure Act by not giving NuVasive Inc. a chance to respond to arguments by Medtronic Inc....To view the full article, register now.
Already a subscriber? Click here to view full article